Evidence map›Paper›PMID 1572089›Full record

ArticleClinical and experimental immunology1992

The profile of IgG and IgG subclasses of onchocerciasis patients.

T H Dafa'alla, H W Ghalib, A Abdelmageed, J F Williams

Abstract read
In one paragraph

Article in Clinical and experimental immunology, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Tropomyosin implicated in host protective responses to microfilariae in onchocerciasis.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  12. Article
  13. Article
  14. Article
  15. Recent advances in tropical medicine.BMJ (Clinical research ed.) · 1994
    Review
  16. Article
  17. Article
  18. Standardization: who wants it?Clinical and experimental immunology · 1992
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

T H Dafa'allaUS NIH/Sudan Medical Parasitology Research Project, Khartoum, Sudan.
H W Ghalib
A Abdelmageed
J F Williams

Funding

IMMUNOLOGY OF ONCHOCERCA VOLVULUS INFECTION AND RESPONSE TO THERAPYP01AI016312 · NIAID · MICHIGAN STATE UNIVERSITY · PI WILLIAMS, JEFFREY F · 1985 to 1993
–
NIAID NIH HHS AI-16312
6 · The paper itself

Abstract

In this study Onchocerca gutturosa was compared with O. volvulus in an ELISA test to detect Onchocerca-specific IgG and IgG subclasses. The test was developed and standardized to detect Onchocerca-specific IgG and IgG subclasses in sera of onchocerciasis patients and endemic controls. Onchocerca volvulus and O. gutturosa crude water-soluble antigens showed no significant difference in detecting onchocerca-specific IgG antibody (T = 1.88, P greater than 0.05). The levels of IgG subclasses varied greatly. IgG4 showed the highest detected mean level (0.84 +/- 0.59) and the other three subclasses showed considerably lower mean levels (IgG1 = 0.27 +/- 0.16, IgG2 = 0.24 +/- 0.17, IgG3 = 0.28 +/- 0.12). The status and score of skin lesions were found to have significant effect on the IgG and IgG subclasses levels (all P less than 0.001). IgG4 showed a positive correlation with the microfilarial (Mf) load (r = 0.21, P less than 0.03). IgG3 levels have a significant negative correlation with the Mf load (r = -0.23, P less than 0.02). The biological significance of these IgG and IgG subclasses in onchocerciasis is discussed.

Indexed as

AdolescentAdultAnimalsAntibodies, HelminthChildEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GMaleMiddle AgedOnchocercaOnchocerciasisAntibodies, HelminthImmunoglobulin G

Identifiers

PMID1572089
PMCPMC1554306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.